Neo-Concept International Group Holdings Ltd (NCI) Stock Analysis
Verdict: AVOID
Severe operational decay and near-depleted cash reserves ($0.3M USD) leave NCI vulnerable to crushing share dilution from shelf offerings.
Investment score: 16/100
Analysis as of
Is Neo-Concept International Group Holdings Ltd stock worth reviewing? AI model thesis
High-risk microcap suffering 37.29% revenue decay, minimal cash reserves ($0.3M USD), class-action legal inquiries, and active dilution shelf filings.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Neo-Concept International Group Holdings Ltd opportunities and risks
What speaks for NCI
- Free Cash Flow Generation in FY2025
What speaks against NCI
- Acute Cash Exhaustion and Insolvency Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| NCI | n/a | 0.0x | 6.0x | 33.5% | -0.3% | 520.1% |
| EDSFF | 0.0x | 0.0x | n/a | 27.1% | 4.0% | -855901.8% |
| Peer median | 0.0x | 0.0x | n/a | 27.1% | 4.0% | -855901.8% |
Frequently asked questions about Neo-Concept International Group Holdings Ltd (NCI)
Is NCI stock a good investment?
The cached TradeMates AI model rates Neo-Concept International Group Holdings Ltd as AVOID with an investment score of 16/100. High-risk microcap suffering 37.29% revenue decay, minimal cash reserves ($0.3M USD), class-action legal inquiries, and active dilution shelf filings. This is algorithmic model output, not personal investment advice.
Is NCI stock a buy?
The TradeMates model verdict for NCI is AVOID with an investment score of 16/100. Treat this as a model signal to review, not a personal buy recommendation.